News

Labcorp announced the expansion of its drug development offering in the Asia-Pacific region with the addition of bioanalytical services in Singapore. “Singapore is a crucial region…
Read More...

Veru Inc. an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, announced that it has enrolled the first…
Read More...

Today, Mandos, LLC (Mandos) announced they have entered into an agreement with Vtesse, LLC, a wholly owned subsidiary of Mallinckrodt Pharmaceuticals (Mallinckrodt), a global…
Read More...

Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company.…
Read More...

Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced that it has agreed to make a controlling investment in Mirus Bio, an innovator and…
Read More...

Bristol-Myers Squibb Company and Agenus Inc. announced that they have entered into a definitive agreement under which Bristol Myers Squibb will be granted a global exclusive license to…
Read More...

Sandoz, a Novartis division, announces plans to further strengthen its European antibiotics manufacturing network by further expanding production capabilities in Kundl, Austria and in…
Read More...

CytoDyn Inc. a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced it…
Read More...

Prestige BioPharma Limited (PBP) and Busan City Government announced that the two organisations have entered into a memorandum of understanding (MOU) for the establishment of Research…
Read More...

BioMed X announced the extension of its ongoing collaboration with Merck. Under the new agreement, Merck will start up to six additional research projects at the BioMed X Institute,…
Read More...

InnoCare a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced that China National Medical Products Administration has approved the Phase I clinical…
Read More...

PerkinElmer, Inc. and Immunodiagnostic Systems Holdings PLC are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer…
Read More...

Charles River Laboratories International, Inc. announced that it has signed a definitive agreement to acquire Vigene Biosciences, Inc., a premier, U.S.-based gene therapy contract…
Read More...

AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced that the US Food and Drug…
Read More...

Lennham Pharmaceuticals, a clinical-stage start-up focused on the creative use of deuterium chemistry to improve the metabolic and pharmacological profile of existing compounds,…
Read More...

In Q4 2020 CordenPharma announced both an expansion of non-GMP capacity at our Centre of Excellence for Peptide Process Development in Frankfurt, Germany, and a major increase in…
Read More...

Dr. Reddy's Laboratories Ltd. and Shenzhen Pregene Biopharma Co., Ltd. announced an agreement whereby Dr Reddy's will acquire an exclusive license in the Republic of India for PRG1801,…
Read More...

Eli Lilly and Company and MiNA Therapeutics Limited, a pioneer in RNA activation therapeutics, announced a global research collaboration to develop novel drug candidates using MiNA's…
Read More...

Novasep, a leading supplier of services and technologies for the life sciences industry, is pleased to announce today a further expansion of its Highly Potent Active Pharmaceutical…
Read More...

PerkinElmer, Inc. is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close during the second…
Read More...